A detailed history of Edgar Lomax CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Edgar Lomax CO holds 199,390 shares of BMY stock, worth $11.5 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
199,390
Previous 202,565 1.57%
Holding current value
$11.5 Million
Previous $8.41 Million 22.66%
% of portfolio
0.63%
Previous 0.55%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $125,920 - $164,306
-3,175 Reduced 1.57%
199,390 $10.3 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $105,857 - $139,363
-2,630 Reduced 1.28%
202,565 $8.41 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $4.27 Million - $4.84 Million
88,933 Added 76.49%
205,195 $11.1 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $256,216 - $305,737
-5,285 Reduced 4.35%
116,262 $5.97 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $259,057 - $289,666
-4,475 Reduced 3.55%
121,547 $7.05 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $111,046 - $123,299
-1,743 Reduced 1.36%
126,022 $8.06 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $1.69 Million - $1.92 Million
-25,750 Reduced 16.77%
127,765 $8.86 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $57,865 - $68,521
-845 Reduced 0.55%
153,515 $11 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $208 - $122,944
-1,600 Reduced 1.03%
154,360 $11 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $309,361 - $340,714
4,260 Added 2.81%
155,960 $12 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $101,442 - $121,638
1,650 Added 1.1%
151,700 $11.1 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $81,249 - $94,717
-1,515 Reduced 1.0%
150,050 $9.36 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $174,551 - $204,464
-2,950 Reduced 1.91%
151,565 $8.97 Million
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $363,721 - $396,092
-5,875 Reduced 3.66%
154,515 $10.3 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $1.03 Million - $1.16 Million
-17,355 Reduced 9.76%
160,390 $10.1 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $178,994 - $202,833
-3,100 Reduced 1.71%
177,745 $11 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $424,982 - $470,936
7,400 Added 4.27%
180,845 $10.9 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $188,854 - $220,790
3,445 Added 2.03%
173,445 $10.2 Million
Q1 2020

May 14, 2020

BUY
$46.4 - $67.43 $7.89 Million - $11.5 Million
170,000 New
170,000 $9.48 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Edgar Lomax CO Portfolio

Follow Edgar Lomax CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.